The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - CytRx Corporation
Leadership - Aquinox; CytRx Corporation
Stock and Other Ownership Interests - Aquinox; CytRx Corporation
Patents, Royalties, Other Intellectual Property - CytRx Corporation
Phase III study of aldoxorubicin vs investigators' choice as treatment for relapsed/refractory soft tissue sarcomas.
 
Sant P. Chawla
Research Funding - CytRx Corporation
 
Kristen N. Ganjoo
Research Funding - CytRx Corporation
 
Scott Schuetze
Honoraria - EMD Serono; EMD Serono; Janssen Research & Development
Consulting or Advisory Role - EMD Serono; EMD Serono; Janssen Research & Development
Research Funding - AB Science (Inst); Amgen (Inst); BioMed Valley Discoveries (Inst); CytRx Corporation (Inst); Janssen Research & Development (Inst); Lilly (Inst); Plexxikon (Inst); Threshold Pharmaceuticals (Inst); ZIOPHARM Oncology (Inst)
 
Zsuzsanna Papai
Research Funding - CytRx Corporation
 
Brian Andrew Van Tine
Consulting or Advisory Role - Caris Life Sciences; CytRx Corporation; EMD Serono; Johnson & Johnson; Lilly/ImClone; Novartis; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; Johnson & Johnson; Lilly; Novartis
 
Edwin Choy
Consulting or Advisory Role - Bayer; EMD Serono; NPS Pharmaceuticals; Pfizer
Research Funding - Amgen (Inst); AstraZeneca (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; EMD Serono; NPS Pharmaceuticals
 
David A. Liebner
Research Funding - CytRx Corporation
 
Mark Agulnik
Consulting or Advisory Role - Eisai; Janssen; Lilly; Novartis
Speakers' Bureau - Eisai; Janssen; Novartis
 
Shanta Chawla
Employment - CytRx Corporation
Stock and Other Ownership Interests - CytRx Corporation
 
Scott Wieland
Employment - CytRx Corporation
Stock and Other Ownership Interests - CytRx Corporation
 
Daniel J. Levitt
No Relationships to Disclose